Log in
Enquire now
AtlasXomics Inc.

AtlasXomics Inc.

A life sciences company in New Haven, Connecticut that aims to develop and commercialize novel technology leveraging Next-Generation Sequencing (NGS).

OverviewStructured DataIssuesContributors

Contents

atlasxomics.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Engineering
Engineering
Life science
Life science
Biomedical engineering
Biomedical engineering
Genetics
Genetics
Genomics
Genomics
Proteomics
Proteomics
Location
New Haven, Connecticut
New Haven, Connecticut
Pitchbook URL
pitchbook.com/profiles...454418-11
Legal Name
AtlasXomics Inc.
Legal classification
Corporation
Corporation
Date Incorporated
February 21, 2020
Full Address
5 SCIENCE PARK ROOM 2E10 NEW HAVEN, CT 06511
CIK Number
1,813,773
Place of Incorporation
Delaware
Delaware
Incorporation Reference
7863216
Founded Date
February 21, 2020
Total Funding Amount (USD)
12,750,003
Latest Funding Round Date
January 6, 2022
Country
United States
United States

Other attributes

Company Operating Status
Active

AtlasXomics Inc. is a life sciences company in New Haven, Connecticut that aims to develop and commercialize novel technology leveraging Next-Generation Sequencing (NGS). Founded 2020 in New Haven, Connecticut, United States, AtlasXomics Inc. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like AtlasXomics Inc.

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.